AstraZeneca - Latest News [Page 1]

International asthma clinical expert to visit NZ

Tuesday, 17 February 2009, 5:20 pm | AstraZeneca

World-renowned asthma researcher Professor Paul M O'Byrne will be in New Zealand between 18 – 24 February. More >>

Stark choice for around 640,000 Kiwis

Monday, 24 November 2008, 3:31 pm | AstraZeneca

Over a half a million older New Zealanders will soon face a stark medical choice - pay for a longstanding medicine that was previously funded, or accept a government-funded generic alternative produced in India. More >>

Breast Cancer Trails Herald Hope

Wednesday, 19 December 2007, 10:03 am | AstraZeneca

New results from one of the world’s largest breast cancer trails herald hope for thousands of women More >>

Hospital Supply in Jeopardy as negotiations stall

Tuesday, 31 July 2007, 2:48 pm | AstraZeneca

PHARMAC’s decision to issue a media statement about the ongoing negotiations with AstraZeneca over Betaloc CR and Plendil ER has confirmed AstraZeneca’s fear that negotiations with PHARMAC have broken down. More >>

NZ Australia gap widening in cholesterol control

Tuesday, 1 May 2007, 11:05 am | AstraZeneca

April, 2007 Recent data from an audit commissioned by pharmaceutical company AstraZeneca of 6,901 heart patients has shown that New Zealand patients with recorded high cholesterol levels and on a cholesterol reducing agent (statins i ) are at least twice as likely ... More >>

Alternative supply of adrenaline for New Zealand

Monday, 22 January 2007, 11:20 am | AstraZeneca

AstraZeneca has secured an approved source of adrenaline to meet the current shortage in New Zealand, General Manager Lance Gravatt said today. More >>

AstraZeneca finalises long-term Zoladex supply

Friday, 23 December 2005, 9:54 am | AstraZeneca

Pharmaceutical company AstraZeneca New Zealand Ltd today announced that it had finalised an agreement with the Pharmaceutical Management Agency of New Zealand (PHARMAC) for the long-term supply of its prostate and breast cancer medicine Zoladex®. More >>

AstraZeneca reaches agreement with PHARMAC

Monday, 19 December 2005, 4:54 pm | AstraZeneca

Pharmaceutical company AstraZeneca New Zealand Ltd today announced that it had reached a verbal agreement with the Pharmaceutical Management Agency of New Zealand (PHARMAC) to continue supplying its prostate and breast cancer medicine Zoladex® to the local ... More >>

Cancer medicine to be withdrawn due to subsidy cut

Thursday, 15 December 2005, 2:31 pm | AstraZeneca

Pharmaceutical company AstraZeneca Limited will withdraw its prostate and breast cancer drug Zoladex from the local market, following a funding cut by the Pharmaceutical Management Agency of New Zealand (PHARMAC). More >>

Breakthrough survival data on Arimidex® released

Monday, 12 December 2005, 11:10 am | AstraZeneca

Post-menopausal women with hormone-sensitive early breast cancer whose tamoxifen treatment is replaced with Arimidex (anastrozole), are likely to reduce their risk of dying by 29%, according to breakthrough new data released today at the San Antonio ... More >>

Top Breast Cancer Experts Share Knowledge In NZ

Monday, 22 August 2005, 11:50 am | AstraZeneca

Some of the world’s most eminent breast cancer experts will share their knowledge and experiences with New Zealanders for the first time in Auckland this November. More >>

Great news for breast cancer patients

Monday, 1 August 2005, 10:26 am | AstraZeneca

Early-stage breast cancer patients who are intolerant to tamoxifen have received great news with the announcement that Pharmac will increase funding of aromatase inhibitors such as Arimidex® from August 1. Pharmac also announced a review of the ... More >>

NZ Asthmatics Do Have Other Alternatives

Monday, 9 May 2005, 10:15 am | AstraZeneca

Asthma sufferers worried about the part charge for Ventolin®, clogging and bad taste of Salamol™ inhalers, need to know there is another fully funded alternative to both Ventolin® and Salamol™ which has the same efficacy. More >>

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL